CAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in endothelial cells. 2006

Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.

Hypertension causes endothelial dysfunction, which plays an important role in atherogenesis. The vascular cell adhesion molecule-1 (VCAM-1) contributes to atherosclerotic lesion formation by recruiting leukocytes from blood into tissues. Tumor necrosis factor-alpha (TNFalpha) induces endothelial dysfunction and VCAM-1 expression in endothelial cells (ECs). We examined whether the cAMP-response element binding protein (CREB), a transcription factor that mediates cytokine expression and vascular remodeling, is involved in TNFalpha-induced VCAM-1 expression. TNFalpha induced phosphorylation of CREB with a peak at 15 min of stimulation in a dose-dependent manner in bovine aortic ECs. Pharmacological inhibition of p38 mitogen-activated protein kinase (p38-MAPK) inhibited TNFalpha-induced CREB phosphorylation. Adenovirus-mediated overexpression of a dominant-negative form of CREB suppressed TNFalpha-induced VCAM-1 and c-fos expression. Although activating protein 1 DNA binding activity was attenuated by overexpression of dominant negative CREB, nuclear factor-kappaB activity was not affected. Our results suggest that the p38-MAPK/CREB pathway plays a critical role in TNFalpha-induced VCAM-1 expression in vascular endothelial cells. The p38MAPK/CREB pathway may be a novel therapeutic target for the treatment of atherosclerosis.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002467 Cell Nucleus Within a eukaryotic cell, a membrane-limited body which contains chromosomes and one or more nucleoli (CELL NUCLEOLUS). The nuclear membrane consists of a double unit-type membrane which is perforated by a number of pores; the outermost membrane is continuous with the ENDOPLASMIC RETICULUM. A cell may contain more than one nucleus. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Cell Nuclei,Nuclei, Cell,Nucleus, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings

Related Publications

Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
March 1999, European journal of pharmacology,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
November 2008, Biological & pharmaceutical bulletin,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
October 2002, FEBS letters,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
November 2011, Journal of inflammation (London, England),
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
January 2004, Drugs under experimental and clinical research,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
November 2005, Toxicology and applied pharmacology,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
June 2004, Journal of thrombosis and haemostasis : JTH,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
September 2005, Atherosclerosis,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
December 1998, The Journal of biological chemistry,
Hiroki Ono, and Toshihiro Ichiki, and Hideki Ohtsubo, and Kae Fukuyama, and Ikuyo Imayama, and Naoko Iino, and Satoko Masuda, and Yasuko Hashiguchi, and Akira Takeshita, and Kenji Sunagawa
November 1997, Arteriosclerosis, thrombosis, and vascular biology,
Copied contents to your clipboard!